Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dibZCfbwocdYsysJwWTV

October 11, 2011
Sign upForwardArchiveAdvertiseRead more at SmartBrief.com
News for nuclear medicine and molecular imaging professionals
 
The news summaries appearing in SNM SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNM prior to publication. Questions and comments may be directed to SmartBrief at snm@smartbrief.com.

  Top Story 
  • PET shows effectiveness of gantenerumab for Alzheimer's disease
    PET with carbon-11-labeled Pittsburgh Compound B showed that treatment with an antibody called gantenerumab can reduce the levels of amyloid-beta plaque in the brains of patients with Alzheimer's disease, according to a Swiss study published in the Archives of Neurology. The reduction in the plaque was directly related to the size of the treatment dose, the researchers said. "Additionally, our findings in the placebo-treated patients support previous reports indicating that amyloid load continues to increase in many patients with mild-to-moderate Alzheimer's disease," the researchers added. AuntMinnie.com (free registration) (10/10) LinkedInFacebookTwitterEmail this Story
 
  Clinical News & Research 
  • California lab receives funding for mass spectrometry device
    The NIH has awarded a $3 million grant to Lawrence Livermore National Laboratory in Livermore, Calif., for the acquisition of a biomedical accelerator mass spectrometry instrument, which will be used for medical and biological research. The device will be used for human tracer tests and body burden evaluations in various areas, including pharmacology, drug development and comparative medicine. MolecularImaging.net (10/10) LinkedInFacebookTwitterEmail this Story
  Industry Report 
  News from the Field 
  • Agfa to launch nuclear medicine product at EANM congress
    Agfa HealthCare is planning to launch its latest version of IMPAX for Nuclear Medicine at the 2011 Congress of the European Association of Nuclear Medicine in the U.K. "At the EANM congress, we will demonstrate how IMPAX for Nuclear Medicine offers clinicians a unique solution that fully integrates the nuclear medicine department's workflow and optimizes inter-departmental communications," said Erik Gielen, nuclear medicine EMEA business manager for Agfa. DOTMed.com/News release (10/10) LinkedInFacebookTwitterEmail this Story
  Featured Content 
 

  Health Policy 
  • California governor rejects breast-density bill
    California Gov. Jerry Brown, a Democrat, has vetoed SB 791, a bill that sought to require mammography providers to inform women regarding their breast density and the possible benefits of further tests. "If the state must mandate a notice about breast density -- and I am not certain it should -- such a notice must be more carefully crafted, with words that educate more than they prescribe," Brown said. MolecularImaging.net (10/10) LinkedInFacebookTwitterEmail this Story
  Advancing Health Care 
  • Chancellor wants to turn USCF into a health sciences innovator
    As the chancellor of the University of California, San Francisco, Dr. Susan Desmond-Hellmann says she wants to transform the university into "the world's pre-eminent health sciences innovator" that can quickly translate research into treatments, provide patients with "unparalleled" care and retain first-rate faculty and staff. Desmond-Hellmann, who served as president of product development at Genentech, said she hoped the university would boost its partnerships with biotech firms in the Bay Area to generate more money in addition to grants, tuition and patient fees being collected by the university. The New York Times (tiered subscription model) (10/10) LinkedInFacebookTwitterEmail this Story
  From SNM 
  • October SNM member deal of the month: "The Best of 2011: Technologist Bundle"
    Save 25% when you purchase 2011's best-selling new releases, bundled together as our member-only deal of the month. This bundle includes: Steves' Review of Nuclear Medicine Technology: Preparation for Certification Examinations, 4th edition; Practical Mathematics in Nuclear Medicine Technology, 2nd edition; and Nuclear Cardiac Imaging: Terminology and Technical Aspects, 2nd edition. Offer ends Oct. 31. Order today. LinkedInFacebookTwitterEmail this Story
SNM  |  Molecular Imaging Community  |  SNM Annual Meeting  |  SNM Learning Center

News  |  SNM on Facebook  |  SNM Channel on YouTube  |  SNM's Virtual March for Health

  SmartQuote 
The reasonable man adapts himself to the world; the unreasonable one persists in trying to adapt the world to himself. Therefore, all progress depends on the unreasonable man."
--George Bernard Shaw,
Irish playwright


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Meryl Harold (202) 407-7828
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent SNM SmartBrief Issues:   Lead Editor:  Adam Gaub
     
Mailing Address:
SmartBrief, Inc.®, 1100 H ST NW, Suite 1000, Washington, DC 20005
 
 
© 1999-2011 SmartBrief, Inc.® Legal Information